Turkiye IS Bankasi A.S.:戦略・SWOT・企業財務分析

◆英語タイトル:Turkiye IS Bankasi A.S. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014592
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月15日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:トルコ
◆産業分野:金融サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Turkiye IS Bankasi A.S. – Strategy, SWOT and Corporate Finance Report
Summary

Turkiye IS Bankasi A.S. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Turkiye Is Bankasi A.S. (Isbank) a banking service provider offers personal and commercial banking and financial services. Its product offering contains housing loans, vehicle loans, SME loans, credit card, prepaid card, debit card, and deposit accounts. Service portfolio of Isbank contains money transfer, securities transactions, safe boxes, debt collection and payment, cheque collection, payment services, and currency exchange services. It offers products and services through a network of branch offices, ATMS, and online portals to individual, SME, and corporate clients in Turkey, Cyprus, the UK, Bahrain, Pristina, Batumi, and Erbil. Isbank is headquartered in Istanbul, Turkey.

Scope

- Detailed information on Turkiye IS Bankasi A.S. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Turkiye IS Bankasi A.S. in the form of a SWOT analysis
- An in-depth view of the business model of Turkiye IS Bankasi A.S. including a breakdown and examination of key business segments
- Intelligence on Turkiye IS Bankasi A.S.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Turkiye IS Bankasi A.S., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Turkiye IS Bankasi A.S. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Turkiye IS Bankasi A.S. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Turkiye IS Bankasi A.S.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Turkiye IS Bankasi A.S.: Company Overview
Turkiye IS Bankasi A.S.: Overview and Key Facts
Turkiye IS Bankasi A.S.: Overview
Turkiye IS Bankasi A.S.: Key Facts
Turkiye IS Bankasi A.S.: Key Employees
Turkiye IS Bankasi A.S.: Key Employee Biographies
Turkiye IS Bankasi A.S.: Major Products and Services
Turkiye IS Bankasi A.S.: Company History
Turkiye IS Bankasi A.S.: Management Statement
Turkiye IS Bankasi A.S.: Locations and Subsidiaries
Turkiye IS Bankasi A.S.: Key Competitors
Turkiye IS Bankasi A.S.: Company Analysis
Turkiye IS Bankasi A.S.: Business Description
Turkiye IS Bankasi A.S.: SWOT Analysis
Turkiye IS Bankasi A.S.: SWOT Overview
Turkiye IS Bankasi A.S.: Strengths
Turkiye IS Bankasi A.S.: Weaknesses
Turkiye IS Bankasi A.S.: Opportunities
Turkiye IS Bankasi A.S.: Threats
Turkiye IS Bankasi A.S.: Corporate Financial Deals Activity
Turkiye IS Bankasi A.S.: Financial Deals Overview
Turkiye IS Bankasi A.S.: Top Deals 2013 – 2017YTD*
Turkiye IS Bankasi A.S.: Advisors
Turkiye IS Bankasi A.S.: Top Financial Advisors
Turkiye IS Bankasi A.S.: Capital Raising
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Turkiye IS Bankasi A.S.: Key Facts
Table 2: Turkiye IS Bankasi A.S.: Key Employees
Table 3: Turkiye IS Bankasi A.S.: Locations and Subsidiaries
Table 4: Turkiye IS Bankasi A.S.: Key Competitors
Table 5: Turkiye IS Bankasi A.S.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Turkiye IS Bankasi A.S.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Turkiye IS Bankasi A.S.: Top Deals 2013 - 2017YTD*
Table 8: Turkiye IS Bankasi A.S.: Financial Advisor Ranking by Value (US$m)
Table 9: Turkiye IS Bankasi A.S.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 10: Turkiye IS Bankasi A.S.: Capital Raising by Deal Type (2013 - YTD*2017)

★海外企業調査レポート[Turkiye IS Bankasi A.S.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neptune Technologies & Bioressources Inc:企業のM&A・事業提携・投資動向
    Neptune Technologies & Bioressources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neptune Technologies & Bioressources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • Ircon International Limited:企業の戦略・SWOT・財務情報
    Ircon International Limited - Strategy, SWOT and Corporate Finance Report Summary Ircon International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • TOR Minerals International Inc (TORM):企業の財務・戦略的SWOT分析
    Summary TOR Minerals International Inc (TOR) is a chemical company that manufactures and distributes mineral and pigment products. The company provides products such as optiload, aluprem, haltex, and others. It also offers alumina trihydrate and boehmite halogen-free flame retardant and smoke suppre …
  • Kadant Inc. (KAI):企業の財務・戦略的SWOT分析
    Kadant Inc. (KAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oil India Ltd (OIL):企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BBX Capital Corporation:企業の戦略・SWOT・財務情報
    BBX Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary BBX Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Getinge AB (GETI B):医療機器:M&Aディール及び事業提携情報
    Summary Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipme …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • Geron Corp (GERN):製薬・医療:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mi …
  • Tecan Group Ltd (TECN)-医療機器分野:企業M&A・提携分析
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • The InterTech Group Inc:企業の戦略的SWOT分析
    The InterTech Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • The Leukemia & Lymphoma Society Inc-製薬・医療分野:企業M&A・提携分析
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a health organization that offers funding research, finding cures and access to treatments for blood cancer patients. The organization’s services include patient support, health education, policy advocacy, funds raising and medical research fundin …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆